Immunovant, Inc. (IMVT)

Immunovant Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	598.91	713.97	635.37	376.53	493.82	400.15
Cash & Short-Term Investments	598.91	713.97	635.37	376.53	493.82	400.15
Cash Growth	6.95%	12.37%	68.74%	-23.75%	23.41%	297.87%
Accounts Receivable	1.94	2.08	5.34	0.7	12.23	0.6
Other Receivables	-	0.43	0.17	0.19	0.63	0.55
Receivables	1.94	2.51	5.5	0.89	12.86	1.14
Prepaid Expenses	50.92	51.18	24.9	26.92	6.25	7.72
Total Current Assets	651.76	767.66	665.77	404.33	512.93	409.01
Property, Plant & Equipment	0.74	0.94	0.6	1.51	2.63	3.48
Other Long-Term Assets	8.94	7.62	-	-	-	-
Total Assets	661.44	776.22	666.37	405.84	515.56	412.49
Accounts Payable	7.84	17.66	7.16	1.35	18.63	2.43
Accrued Expenses	45.06	50.75	41.3	40.42	24.58	15.16
Current Portion of Leases	-	0.1	0.14	1.17	1.15	1.18
Other Current Liabilities	-	0.27	0.02	0.35	0.17	-
Total Current Liabilities	52.9	68.78	48.61	43.3	44.52	18.77
Long-Term Leases	-	-	-	0.05	1.22	2.24
Total Liabilities	52.9	68.78	48.61	43.34	45.74	21.01
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,967	1,945	1,442	927.98	824.8	590.43
Retained Earnings	-1,360	-1,240	-825.68	-566.35	-355.39	-198.66
Comprehensive Income & Other	1.74	1.46	1.91	0.85	0.4	-0.3
Shareholders' Equity	608.54	707.45	617.76	362.49	469.83	391.48
Total Liabilities & Equity	661.44	776.22	666.37	405.84	515.56	412.49
Total Debt	-	0.1	0.14	1.22	2.36	3.42
Net Cash (Debt)	598.91	713.87	635.23	375.31	491.45	396.73
Net Cash Growth	6.96%	12.38%	69.25%	-23.63%	23.88%	307.40%
Net Cash Per Share	3.80	4.71	4.60	3.05	4.48	4.52
Filing Date Shares Outstanding	174.32	170.92	146.05	130.41	116.51	97.98
Total Common Shares Outstanding	171.07	170.11	145.58	130.33	116.48	97.97
Working Capital	598.86	698.89	617.16	361.04	468.41	390.24
Book Value Per Share	3.56	4.16	4.24	2.78	4.03	4.00
Tangible Book Value	608.54	707.45	617.76	362.49	469.83	391.48
Tangible Book Value Per Share	3.56	4.16	4.24	2.78	4.03	4.00

Updated May 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q